Karen S McCoy, MD - Publications

Affiliations: 
Ohio State University, Columbus, Columbus, OH 

46 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Heijerman HGM, McKone EF, Downey DG, Van Braeckel E, Rowe SM, Tullis E, Mall MA, Welter JJ, Ramsey BW, McKee CM, Marigowda G, Moskowitz SM, Waltz D, Sosnay PR, Simard C, ... ... McCoy KS, et al. Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial. Lancet (London, England). PMID 31679946 DOI: 10.1016/S0140-6736(19)32597-8  0.309
2019 Goetz D, Kopp BT, Salvator A, Moore-Clingenpeel M, McCoy K, Leung DH, Kloster M, Ramsey BR, Heltshe SH, Borowitz D. Pulmonary findings in infants with cystic fibrosis during the first year of life: Results from the Baby Observational and Nutrition Study (BONUS) cohort study. Pediatric Pulmonology. PMID 30672141 DOI: 10.1002/Ppul.24261  0.357
2019 Goss C, Heltshe S, Aitken M, Hornick D, Lechtzin N, McCoy K, Skalland M, Mayer-Hamblett N, Teresi M, Singh P. WS01-3 IV gallium nitrate demonstrates biological activity for chronic Pseudomonas aeruginosa infection in cystic fibrosis Journal of Cystic Fibrosis. 18. DOI: 10.1016/S1569-1993(19)30119-5  0.326
2018 Kopp BT, Joseloff E, Goetz D, Ingram B, Heltshe SL, Leung DH, Ramsey BR, McCoy K, Borowitz D. Urinary metabolomics reveals unique metabolic signatures in infants with cystic fibrosis. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 30477895 DOI: 10.1016/J.Jcf.2018.10.016  0.342
2018 Robledo-Avila FH, Ruiz-Rosado JD, Brockman KL, Kopp BT, Amer AO, McCoy K, Bakaletz LO, Partida-Sanchez S. Dysregulated Calcium Homeostasis in Cystic Fibrosis Neutrophils Leads to Deficient Antimicrobial Responses. Journal of Immunology (Baltimore, Md. : 1950). PMID 30120123 DOI: 10.4049/Jimmunol.1800076  0.364
2018 Sheikh S, Pitts J, Salvator A, Nemastil C, Ulrich L, May A, Mccoy K. Impact Of Race On Long-Term Asthma Control In Children Chest. 154. DOI: 10.1016/J.Chest.2018.08.730  0.306
2017 Zemanick ET, Wagner BD, Robertson CE, Ahrens RC, Chmiel JF, Clancy JP, Gibson RL, Harris WT, Kurland G, Laguna TA, McColley SA, McCoy K, Retsch-Bogart G, Sobush KT, Zeitlin PL, et al. Airway microbiota across age and disease spectrum in cystic fibrosis. The European Respiratory Journal. 50. PMID 29146601 DOI: 10.1183/13993003.00832-2017  0.416
2017 Freedman S, Orenstein D, Black P, Brown P, McCoy K, Stevens J, Grujic D, Clayton R. Increased Fat Absorption from Enteral Formula Through an In-Line Digestive Cartridge in Patients with Cystic Fibrosis. Journal of Pediatric Gastroenterology and Nutrition. PMID 28471913 DOI: 10.1097/Mpg.0000000000001617  0.329
2016 Sheikh S, Handly B, Ryan-Wenger N, Hayes D, Kirkby S, McCoy K, Lind M. Novel CT Scoring System for Sinus Disease in Adults With Cystic Fibrosis Chest. 150: 655A. DOI: 10.1016/J.Chest.2016.08.749  0.306
2016 Sheikh S, Handly B, Ryan-Wenger N, Hayes D, Ramanathan C, McCoy K, Lind M. A New CT Scoring System for Sinus Disease in Children With Cystic Fibrosis Chest. 150: 1133A. DOI: 10.1016/J.Chest.2016.08.1243  0.346
2016 Sheikh S, Pitts J, Ryan-Wenger N, Stukus D, Kotha K, McCoy K. Impact of Following Asthma Guidelines on Quality of Life of Families With Asthmatic Children: Long-term Follow-up Chest. 150: 960A. DOI: 10.1016/J.Chest.2016.08.1063  0.302
2015 Wainwright CE, Elborn JS, Ramsey BW, Marigowda G, Huang X, Cipolli M, Colombo C, Davies JC, De Boeck K, Flume PA, Konstan MW, McColley SA, McCoy K, McKone EF, Munck A, et al. Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR. The New England Journal of Medicine. 373: 220-31. PMID 25981758 DOI: 10.1056/Nejmoa1409547  0.375
2015 Sheikh S, Handly B, Ryan-Wenger N, Kirkby S, Ramanathan C, McCoy K, Hayes D, Lind M. LATE-BREAKING ABSTRACT: A new, easy to use computed tomography based scoring system for sinus disease in cystic fibrosis: Validated with acceptable inter- and intra-rater reliability European Respiratory Journal. 46. DOI: 10.1183/13993003.Congress-2015.Pa3736  0.339
2015 Sheikh S, Pitts J, Ryan-Wenger N, Stukus D, McCoy K, Kotha K. Following asthma guidelines improves quality of life in children with asthma European Respiratory Journal. 46. DOI: 10.1183/13993003.Congress-2015.Pa1277  0.337
2015 Sheikh S, Pitts J, McCoy K. Asthma guidelines need to be followed at primary care level to improve symptom control in children European Respiratory Journal. 46. DOI: 10.1183/13993003.Congress-2015.Pa1276  0.338
2014 Swender DA, Thompson G, Schneider K, McCoy K, Patel A. Osteopathic manipulative treatment for inpatients with pulmonary exacerbations of cystic fibrosis: effects on spirometry findings and patient assessments of breathing, anxiety, and pain. The Journal of the American Osteopathic Association. 114: 450-8. PMID 24917632 DOI: 10.7556/Jaoa.2014.095  0.382
2014 Woodley FW, Machado RS, Hayes D, Di Lorenzo C, Kaul A, Skaggs B, McCoy K, Patel A, Mousa H. Children with cystic fibrosis have prolonged chemical clearance of acid reflux compared to symptomatic children without cystic fibrosis. Digestive Diseases and Sciences. 59: 623-30. PMID 24287640 DOI: 10.1007/S10620-013-2950-0  0.397
2013 Sheikh S, Pitts J, Ryan-Wenger N, McCoy K. In Children With Family History of Asthma, Does Gender Increase Their Risk for Asthma Chest. 144: 763A. DOI: 10.1378/Chest.1675911  0.306
2013 Sheikh S, Ryan-Wenger N, Patel A, McCoy K, Kirkby S. Lobectomy in Cystic Fibrosis Chest. 144: 778A. DOI: 10.1378/Chest.1675846  0.382
2012 Kopp BT, Abdulrahman BA, Khweek AA, Kumar SB, Akhter A, Montione R, Tazi MF, Caution K, McCoy K, Amer AO. Exaggerated inflammatory responses mediated by Burkholderia cenocepacia in human macrophages derived from Cystic fibrosis patients. Biochemical and Biophysical Research Communications. 424: 221-7. PMID 22728038 DOI: 10.1016/J.Bbrc.2012.06.066  0.334
2012 Hayes D, Kopp B, Mansour H, Kirkby S, Yates A, McCoy K, Daniels C. Exercise-Induced Pulmonary Arterial Hypertension in Pediatric and Young Adult Patients With Cystic Fibrosis Chest. 142: 773A. DOI: 10.1378/Chest.1388349  0.317
2011 Kirkby S, Novak K, McCoy K. Aztreonam (for inhalation solution) for the treatment of chronic lung infections in patients with cystic fibrosis: an evidence-based review. Core Evidence. 6: 59-66. PMID 22022288 DOI: 10.2147/Ce.S11181  0.418
2011 Abdulrahman BA, Khweek AA, Akhter A, Caution K, Kotrange S, Abdelaziz DH, Newland C, Rosales-Reyes R, Kopp B, McCoy K, Montione R, Schlesinger LS, Gavrilin MA, Wewers MD, Valvano MA, et al. Autophagy stimulation by rapamycin suppresses lung inflammation and infection by Burkholderia cenocepacia in a model of cystic fibrosis. Autophagy. 7: 1359-70. PMID 21997369 DOI: 10.4161/Auto.7.11.17660  0.331
2011 Sheikh S, Quach J, McCoy K. Nissen Fundoplication in Patients With Cystic Fibrosis. Impact on Nutrition Chest. 140: 385. DOI: 10.1378/Chest.1114003  0.366
2011 Sheikh S, Morris K, McCoy K. In African American Children, Is Socioeconomic Status an Important Factor in Determining Risk for Asthma. A Pilot Study Chest. 140: 3-8. DOI: 10.1378/Chest.1111903  0.307
2011 Pitts J, Sheikh S, McCoy K. Omalizumab in Children With Moderate to Severe Allergic Asthma. Our Limited Experience Chest. 140: 3-7. DOI: 10.1378/Chest.1111881  0.323
2011 Sheikh S, Quach J, McCoy K. Nissen Fundoplication in Patients With Cystic Fibrosis and Severe GERD. Impact on Lung Disease Chest. 140: 906. DOI: 10.1378/Chest.1107183  0.366
2010 Oermann CM, Retsch-Bogart GZ, Quittner AL, Gibson RL, McCoy KS, Montgomery AB, Cooper PJ. An 18-month study of the safety and efficacy of repeated courses of inhaled aztreonam lysine in cystic fibrosis. Pediatric Pulmonology. 45: 1121-34. PMID 20672296 DOI: 10.1002/Ppul.21301  0.304
2010 Woodley FW, Hayes J, Patel A, McCoy K, Mousa H. T1692 The Association Between Acid Reflux and Cough in Patients With Cystic Fibrosis is Not Dependent on the Type of Acid Reflux Gastroenterology. 138. DOI: 10.1016/S0016-5085(10)62570-X  0.336
2009 Kirkby S, Novak K, McCoy K. Update on antibiotics for infection control in cystic fibrosis. Expert Review of Anti-Infective Therapy. 7: 967-80. PMID 19803706 DOI: 10.1586/Eri.09.82  0.372
2008 McCoy KS, Quittner AL, Oermann CM, Gibson RL, Retsch-Bogart GZ, Montgomery AB. Inhaled aztreonam lysine for chronic airway Pseudomonas aeruginosa in cystic fibrosis. American Journal of Respiratory and Critical Care Medicine. 178: 921-8. PMID 18658109 DOI: 10.1164/Rccm.200712-1804Oc  0.329
2008 Retsch-Bogart GZ, Burns JL, Otto KL, Liou TG, McCoy K, Oermann C, Gibson RL. A phase 2 study of aztreonam lysine for inhalation to treat patients with cystic fibrosis and Pseudomonas aeruginosa infection. Pediatric Pulmonology. 43: 47-58. PMID 18041081 DOI: 10.1002/Ppul.20736  0.39
2008 McCoy K, Retsch-Bogart G, Gibson R, Oermann C, Braff M, Montgomery A. Microbiologic resistance and clinical efficacy of aztreonam lysine for inhalation (AZLI) in cystic fibrosis (CF) Journal of Cystic Fibrosis. 7: S36. DOI: 10.1016/S1569-1993(08)60138-1  0.356
2008 Oermann C, McCoy K, Retsch-Bogart G, Gibson R, Quittner A, Montgomery A. Effect of multiple aztreonam lysine for inhalation (AZLI) cycles on disease-related endpoints and safety in patients with cystic fibrosis (CF) and Pseudomonas aeruginosa (PA): Interim analysis of 12 month data Journal of Cystic Fibrosis. 7: S25. DOI: 10.1016/S1569-1993(08)60097-1  0.382
2007 McCoy K, Retsch-Bogart G, Oermann C, Gibson R, Montgomery A. 40* Aztreonam lysine for inhalation (AZLI) for CF patients with P. aeruginosa (PA) infection Journal of Cystic Fibrosis. 6: S10. DOI: 10.1016/S1569-1993(07)60033-2  0.355
2006 McCoy K, Shade DM, Irvin CG, Mastronarde JG, Hanania NA, Castro M, Anthonisen NR. Predicting episodes of poor asthma control in treated patients with asthma. The Journal of Allergy and Clinical Immunology. 118: 1226-33. PMID 17157651 DOI: 10.1016/J.Jaci.2006.09.006  0.319
2003 Ernst RK, D'Argenio DA, Ichikawa JK, Bangera MG, Selgrade S, Burns JL, Hiatt P, McCoy K, Brittnacher M, Kas A, Spencer DH, Olson MV, Ramsey BW, Lory S, Miller SI. Genome mosaicism is conserved but not unique in Pseudomonas aeruginosa isolates from the airways of young children with cystic fibrosis. Environmental Microbiology. 5: 1341-9. PMID 14641578 DOI: 10.1111/J.1462-2920.2003.00518.X  0.34
2003 Varekojis SM, Douce FH, Flucke RL, Filbrun DA, Tice JS, McCoy KS, Castile RG. A comparison of the therapeutic effectiveness of and preference for postural drainage and percussion, intrapulmonary percussive ventilation, and high-frequency chest wall compression in hospitalized cystic fibrosis patients. Respiratory Care. 48: 24-8. PMID 12556258  0.324
2001 Rosenfeld M, Gibson RL, McNamara S, Emerson J, Burns JL, Castile R, Hiatt P, McCoy K, Wilson CB, Inglis A, Smith A, Martin TR, Ramsey BW. Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis. Pediatric Pulmonology. 32: 356-66. PMID 11596160 DOI: 10.1002/Ppul.1144  0.401
2001 Burns JL, Gibson RL, McNamara S, Yim D, Emerson J, Rosenfeld M, Hiatt P, McCoy K, Castile R, Smith AL, Ramsey BW. Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis. The Journal of Infectious Diseases. 183: 444-52. PMID 11133376 DOI: 10.1086/318075  0.404
2000 Castile R, Filbrun D, Flucke R, Franklin W, McCoy K. Adult-type pulmonary function tests in infants without respiratory disease. Pediatric Pulmonology. 30: 215-27. PMID 10973040 DOI: 10.1002/1099-0496(200009)30:3<215::Aid-Ppul6>3.0.Co;2-V  0.326
1999 Rosenfeld M, Emerson J, Accurso F, Armstrong D, Castile R, Grimwood K, Hiatt P, McCoy K, McNamara S, Ramsey B, Wagener J. Diagnostic accuracy of oropharyngeal cultures in infants and young children with cystic fibrosis. Pediatric Pulmonology. 28: 321-8. PMID 10536062 DOI: 10.1002/(Sici)1099-0496(199911)28:5<321::Aid-Ppul3>3.0.Co;2-V  0.358
1998 Piedra PA, Poveda GA, Ramsey B, McCoy K, Hiatt PW. Incidence and prevalence of neutralizing antibodies to the common adenoviruses in children with cystic fibrosis: implication for gene therapy with adenovirus vectors. Pediatrics. 101: 1013-9. PMID 9606228 DOI: 10.1542/Peds.101.6.1013  0.351
1996 McCoy K, Hamilton S, Johnson C. Effects of 12-week administration of dornase alfa in patients with advanced cystic fibrosis lung disease Chest. 110: 889-895. PMID 8874241 DOI: 10.1378/Chest.110.4.889  0.378
1996 Wilmott RW, Amin RS, Colin AA, DeVault A, Dozor AJ, Eigen H, Johnson C, Lester LA, McCoy K, McKean LP, Moss R, Nash ML, Jue CP, Regelmann W, Stokes DC, et al. Aerosolized recombinant human DNase in hospitalized cystic fibrosis patients with acute pulmonary exacerbations. American Journal of Respiratory and Critical Care Medicine. 153: 1914-7. PMID 8665055 DOI: 10.1164/Ajrccm.153.6.8665055  0.377
1985 Zipf WB, McCoy K, O'Dorisio T. 757 PRIMARY PANCREATIC POLYPEPTIDE (PP) DEFICIENCY IN CHILDREN WITH CYSTIC FIBROSIS Pediatric Research. 19: 237A-237A. DOI: 10.1203/00006450-198504000-00787  0.36
Show low-probability matches.